Member Info for Brighty1

Yes, as a CERP holder I'm looking forward to August 7th and the combined BPC / CERP business. A much bigger proposition now plus a Q4 drill that could, as LK states, be transformational. Good luck, Brighty

SAR takeover in the pipeline / Licencing / Covid / Sierra? Yes Bobat 123, Mazik and Basser, various announcements due soon which could and should propel the share price significantly. e.g. China Aurora news, 737 Sierra, licencing of TYK2/JAK1 or maybe a Covid grant or as Searle and others have suggested a takeover of Sar? It is rare for an AIM stock to be sitting on such a gold mine of announcements. We just need Sareum to start communicating. Good luck, Brighty

BOIL x 5 quite possible soon i.e. 0.54 just 6 months ago.
Bearing in mind this was 0.54 on February 7th this could quite easily go back up very quickly AND 0.54 was pre the fund raising and agreement re Timor. Looking very interesting now. Good luck, Brighty

Some TOM stats to digest. A year ago TOM was above 8p with hopes of developing a plant but they had minimal cash. That’s all changed now - Tom is a sturdier and much less chancy company in August 2020 at this price than it was at 8p just 12 months ago. You also need to factor in that TOM has a 100% investment in 9 shale leases, of over 15,488 acres in Utah. Now, when you consider that 10,000 bopd compares to approx $430,000 a day they could be generating returns equal to the entire current mcap of TOM every 9-10 days. Proactive Investors ran an excellent research article on this recently. This is why at some stage TOM will be back in the 8-10p range in the next few months. When it happens that is a x 10 multi bag from today. Good luck, Brighty.

https://www.proactiveinvestors.co.uk/companies/news/922129/tomco-energy-analyst-highlights-attractive-economics-of-a-new-oil-sands-separation-technology-922129.html

There were loads of inferences and comments made on the ceo's appointment about the financial success which had been shared with easyjet shareholders with a more than trebling of easyJet's share price and the payment of £1.2 billion in dividends. Well, that has not happened at ITV. The Ceo was appointed on July 17th 2017 with the share price at 175p. Our Ceo started on 8th January 2018 with the share price at 168p. That was 2 years in to Brexit, so no excuses. The SP is now at 54p and no dividends. Are share holders not worried about this? The ceo and chair need to talk up the value of the ITV business rather than all the corporate stuff that we know anyway. Under the previous Ceo, whether you liked him or not, the market believed in the ITV (and ITV studios) story. This needs to be the focus moving forward. The value in the business is huge but it's not being talked up. Brighty

Change of CEO required. We have the wrong ceo at the wrong time. We need a visionary / communicator. A lot of ground to make up to get the share price back up and can't see Carolyn McCall doing this for us. ITV has so much going for it but the buzz and excitement about our prospects just isn't communicated by the ceo / board. We need positivity and a strategy to convince the market of ITV's true value. This never gets communicated by the new regime. At least under the previous regime the market believed in the ITV story. Come on Carolyn McCall please start talking up ITV's true value rather than all the corporate speak. It's time to convince the market that you were the right pick for ceo or it's time to move on. Brighty.

TOM TR1 Over 3%. David McBride showing confidence in TOM.
Over 3% 673,634,235 shares
Good news.
Brighty.

The more blue chip clients PYC has the more chance one of them will acquire PYC. It's a lot more cost effective for a major to buy PYC. Astellas Pharma could be trying out the PYC technology for all we know before potentially considering an acquisition. Check out the recent M&A activity in this space and you will see what I mean. There have been a spate of significant takeover's in this area. Contract is good news but who they are doing it with is even more of interest. Good luck, Brighty

The AZN pipeline would be enhanced if they acquired Synairgen and Sareum. Brighty

Highland Gold sold today for £3 a share. For those that held Highland since the 27p days 6 years ago fantastic news. Encouraging for Altn that M&A activity is hotting up in the gold sector. Right sector to be in during the pandemic. I still feel this will be sold for 16p+ a share. Brighty

I'm here for when PYC are acquired for many multiples of today's share price. This contract is great news. The deals PYC are striking get bigger and bigger. If you research the recent M&A activity in this space you will see that there has been a spate of significant M&A activity in this area. Good luck, Brighty

Damion, very interesting to read your "Amgen to Acquire Sareum Holdings @ 7.5p per share"...... Brighty

Many are missing the point here. The more blue chip clients they have the more chance one of them will buy PYC lock stock and barrel. It will be a lot more cost effective for a major pharma to buy PYC than start from scratch and attempt to replicate the PYC product. That's what M&A is about and PYC's client bank indicates that they have at least half a dozen significant pharmas who could acquire them. Astellas Pharma could be trying out the PYC technology for all we know before potentially considering an acquisition. The contract is great news but the implications are even more interesting. Check out the recent M&A activity in this space and you will see what I mean. There have been a spate of significant £££ acquisitions in this area. Good luck, Brighty

Great news plus this latest contract could well be a forerunner to being acquired by Astellas Pharma or ANother. PYC in the right place at the right time. Brighty

Yes PhilBoro, a multibagger x 28 from 1p to 28p would be about right for Sareum. Judging by the recent gains for ODX up x 13, AVCT up x 15, Hemo up x 15, SNG up x 40, NCYT up x 75, PYC up x 11, why not indeed. It is clearly possible. Thoth has said 28p for years. He might well be right. Sareum is in the right place at the right time. Just need the various RNS' to drop. Good luck, Brighty.

The gains could be massive here, as we have seen with our rivals:ODX 7p to 91p multiplied by x 13 in 6 monthsAVCT 14p – 215p multiplied by x 15 in 6 monthsHEMO 1p to 15p multiplied by x 15 in 6 monthsSNG 6p to 240p multiplied x 40 in 6 monthsNCYT 7p to 527p Multiplied by x 75 in 6 monthsPYC 1.5p to 17p multiplied by x 11 in 6 monthsDyor and good luck, Brighty

PhilBoro, no just waiting for news on one or more of the following: Searle suggesting that a takeover is a possibility? We also have the China Aurora news to watch out for. Or the news on 737 Sierra? Or licencing of TYK2/JAK1? or maybe a Covid grant? A multitude of news options to be RNS'd. Which is it, if any? Good luck, Brighty

It's actually the CIO doing the interview, Adam Warne. He joined in 2018 as Chief Information Officer from AO. Steve Johnson is the CEO. Interesting to see the heavy recruitment going on at the moment. That is a good sign also. II buying is very favourable message too. Brighty

With so many of our AIM listed pharma rivals multi-bagging surely now is the time to hold for gold and not sell Sareum for under a penny....
ODX 7p to 91p multiplied by x 13 in 6 months
AVCT 14p – 215p multiplied by x 15 in 6 months
HEMO 1p to 15p multiplied by x 15 in 6 months
SNG 6p to 240p multiplied x 40 in 6 months
NCYT 7p to 527p Multiplied by x 75 in 6 months
PYC 1.5p to 17p multiplied by x 11 in 6 months

Dyor and good luck, Brighty.

Could it be as Searle suggests that a takeover is a possibility? We also have the China Aurora news to watch out for. Or the news on 737 Sierra? Or licencing of TYK2/JAK1? or maybe a Covid grant? A multitude of news options to be RNS'd. Which is it, if any? Good luck, Brighty